Through CB1 and CB2, these endocannabinoids amplify lipogenesis and decrease energy expenditure, contributing to obesity (Iannotti and Vitale, 2021; Pertwee et al., 2010; Lu and Mackie, 2021). Here, CNR1 is linked to obesity disorder.